Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2013 Sep;41(9):2209-20.
doi: 10.1097/CCM.0b013e31828cf412.

Blood purification and mortality in sepsis: a meta-analysis of randomized trials

Feihu Zhou  1 , Zhiyong Peng, Raghavan Murugan, John A Kellum
Affiliations
Meta-Analysis

Blood purification and mortality in sepsis: a meta-analysis of randomized trials

Feihu Zhou et al. Crit Care Med. 2013 Sep.

Abstract

Objectives: Although blood purification improves outcomes in animal studies of sepsis, results of clinical trials have been mixed. We conducted a systematic review and meta-analysis of randomized trials to determine the association between various blood purification techniques and all-cause mortality in humans with sepsis.

Data sources: We searched for relevant studies in MEDLINE, EMBASE, and the Cochrane Library database from January 1966 to May 2012.

Study selection: Inclusion required a diagnosis of sepsis and comparison of blood purification techniques including hemofiltration, hemoperfusion, plasma exchange, or hemodialysis with no blood purification (control group).

Data extraction: Two authors independently selected studies and extracted data. Summary statistics, risk ratios, and CIs were calculated using random-effects modeling. Study quality was assessed using Jadad score, and publication bias was assessed using funnel plots and Egger's statistic.

Data synthesis: Overall, blood purification decreased mortality compared with no blood purification (35.7% vs 50.1%; risk ratio, 0.69 [95% CI, 0.56-0.84]; p<0.001; 16 trials, n=827). However, these results were driven mainly by hemoperfusion (risk ratio, 0.63 [95% CI, 0.50-0.80]; p<0.001; 10 trials, n=557) and plasma exchange (risk ratio, 0.63 [95% CI, 0.42-0.96]; p=0.03; two trials, n=128). Pooling of all trials of blood purification for treatment of sepsis was no longer associated with lower mortality (risk ratio, 0.89 [95% CI, 0.71-1.13]; p=0.36; eight trials, n=457) after excluding trials using polymyxin B hemoperfusion.

Conclusions: Blood purification techniques including hemoperfusion, plasma exchange, and hemofiltration with hemoperfusion were associated with lower mortality in patients with sepsis. These results were mainly influenced by studies using polymyxin B hemoperfusion from Japan.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Quorum Chart of Study Cohort.
Figure 2
Figure 2
Risk Ratios (RRs) for Blood Purification versus Conventional Treatment. Pooled risk ratios are from a random effects model; CI indicates confidence interval; Size of the data markers indicates weight of the study.
Figure 3
Figure 3
Risk Ratios (RRs) for Different Modality of Blood Purification versus Conventional Treatment. Pooled risk ratios are from a random effects model; CI indicates confidence interval; Size of the data markers indicates weight of the study.

  1. Different modalities of blood purification versus conventional treatment.

  2. Different geographic region and hemoperfusion analysis of blood purification versus conventional treatment.

Figure 3
Figure 3
Risk Ratios (RRs) for Different Modality of Blood Purification versus Conventional Treatment. Pooled risk ratios are from a random effects model; CI indicates confidence interval; Size of the data markers indicates weight of the study.

  1. Different modalities of blood purification versus conventional treatment.

  2. Different geographic region and hemoperfusion analysis of blood purification versus conventional treatment.

Figure 4
Figure 4
Assessment of Publication Bias.

  1. A funnel plot.

  2. Egger’s test

Figure 4
Figure 4
Assessment of Publication Bias.

  1. A funnel plot.

  2. Egger’s test

See this image and copyright information in PMC

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29:1303–1310. - PubMed
    1. Martin GS, Mannino DM, Eaton S, et al. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;48:1546–1554. - PubMed
    1. Xigris [drotrecogin alfa (activated)]: Market Withdrawal -Failure to Show Survival Benefit. [Accessed January 15, 2013]; http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHuma....
    1. Dellinger RP, Levy MM, Carlet JM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med. 2008;34:17–60. - PMC - PubMed
    1. Joannidis M. Continuous renal replacement therapy in sepsis and multisystem organ failure. Semin Dial. 2009;22:160–164. - PubMed

Publication types